Using a population-based cancer registry for recruitment of newly diagnosed patients with ovarian cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 1, 2005, Pages 17-20

  Andersen, M Robyn ^a,b,d   Schroeder, Tom ^a   Gaul, Marcia ^a   Moinpour, Carol ^a   Urban, Nicole ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Marsha Rivkin Ctr Ovarian Cancer R   (United States)

^d MP 900 ^*  (United States)

Author keywords

Clinical trials; Ovarian cancer; Recruitment; Survivors

Indexed keywords

ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PHYSICIAN; QUALITY OF LIFE;

ADAPTATION, PSYCHOLOGICAL; ADULT; CLINICAL TRIALS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PATIENT SELECTION; QUALITY OF LIFE; REGISTRIES; SOCIAL SUPPORT;

EID: 13444300925     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000138967.62532.2e     Document Type: Article

References (13)

1. Rothman KJ. Modern Epidemiology. Boston: Little, Brown; 1986.
2. Kelsey J, Whittemore A, Evans A, et al. Methods in Observational Epidemiology, 2nd ed. New York: Oxford University Press; 1996.
3. Newcomb PA, Love R, Phillips MS, et al. Using a population-based cancer registry for recruitment in a pilot cancer control study. Prev Med. 1990;19:61-65.
4. Disis ML, Gooley TA, Rinn K, et al. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines. J Clin Oncol. 2002;20:2624-2632.
5. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 1995;14:101-108.
6. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
7. Lee J, Marks J, Simpson J. Recruitment of patients to cooperative group clinical trials. Cancer Clin Trials. 1980;3:1-4.
8. Spiro SG, Gowera NH, Evans MT, et al. Recruitment of patients with lung cancer into a randomised clinical trial: experience at two centres. On behalf of the Big Lung Trial Steering Committee. Thorax. 2000;55: 463-465.
9. Hunter CP, Frelick RW, Feldman AR, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Rep. 1987;71:559-565.
10. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patient 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061-2067.
11. Lovato LC, Hill K, Hertert S, et al. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1997;18:328-357.
12. Taylor KM, Margolese RG, Soskoline CL. Physicians' reasons for not entering eligible patients in a randomized clinical trail of surgery for breast cancer. N Engl J Med. 1984;310:1363-1367.
13. Benson AB, Pregler JP, Bean JA, et al. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1991;9:2067-2075.